- Rosuvax is primarily indicated in conditions like Hypercholesterolaemia, Hyperlipidaemia, and can also be given in adjunctive therapy as an alternative drug of choice in Hypertriglyceridaemia
- Rosuvax is contraindicated in conditions like Liver diseases, Pregnancy. Lactation, Renal impairment, Hypersensitivity to any component of product
- Rosuvax produces potentially life-threatening effects which include Abdominal pain, Myalgia which are responsible for the discontinuation of Rosuvax therapy. The symptomatic adverse reactions produced by Rosuvax are more or less tolerable and if they become severe, they can be treated symptomatically, these include Duziness. Headache Nausea. Asthenia, Hypersensitivity, Pancreatitis
Rosuvax therapy should be discontinued if markedly elevated creatinine kinase levels occur or myopathy is diagnosed or suspected. Rosuvax therapy should also be temporarily withheld in any patient with an acute serious condition suggestive of myopathy or predisposing to the development of renal failure secondary to rhabdomyolysis. Should be used with caution in patients who consume substantial quantities of alcohol and/or have a history of chronic liver disease.